multiple pregnancy - Nursing Case Study

Pathophysiology

• Primary mechanism: Hyperovulation, often driven by elevated gonadotropin levels or fertility treatments, increases the chance of multiple eggs being released and fertilized, leading to dizygotic (fraternal) twins or higher-order multiples.

• Secondary mechanism: In cases of monozygotic (identical) multiples, a single fertilized egg divides into two or more embryos. The timing of this division determines the type of shared placental and amniotic structures, influencing pregnancy risk levels.

• Key complication: Increased maternal and fetal risks, such as preterm labor, preeclampsia, and intrauterine growth restriction, arise from the additional physiological demands and potential for shared or competing resources between fetuses.

Patient Profile

Demographics:

32-year-old female, teacher

History:

• Key past medical history: Gestational diabetes in a previous pregnancy, hypertension

• Current medications: Prenatal vitamins, labetalol

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased abdominal pain and pressure

• Key symptoms: Frequent contractions, swelling in the legs, shortness of breath

• Vital signs: Blood pressure 150/95 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 94% on room air

Section 1

The initial assessment findings reveal several concerning developments in the patient's condition. On examination, the obstetrician notes that the patient is experiencing frequent and regular contractions occurring every 10 minutes, raising the suspicion of preterm labor. The abdominal palpation confirms the presence of multiple fetal parts, suggestive of a twin pregnancy. The uterine fundus measures larger than expected for gestational age, corroborating the suspicion of multiple gestations. Notably, there is significant pitting edema in the patient's lower extremities, and her reflexes are brisk, indicating potential worsening of her hypertensive condition.

Laboratory investigations reveal a proteinuria of 0.5 g/day, which, along with the elevated blood pressure, suggests the development of preeclampsia. Additionally, complete blood count shows a mild thrombocytopenia with a platelet count of 120,000/mm³, raising concerns for HELLP syndrome, a severe form of preeclampsia. The fetal non-stress test indicates variable decelerations, suggesting possible fetal distress, which may be a result of compromised uteroplacental blood flow. An ultrasound confirms dichorionic, diamniotic twins with discordant growth patterns, as the estimated fetal weights show a 25% discrepancy, raising concerns for intrauterine growth restriction in one of the fetuses.

Given these findings, the clinical team must prioritize stabilizing the mother's condition to prolong the pregnancy while minimizing risks to both her and the fetuses. The nursing staff will implement continuous fetal monitoring, initiate magnesium sulfate for seizure prophylaxis, and administer corticosteroids to enhance fetal lung maturity in anticipation of potential preterm delivery. The developing complications necessitate careful balancing of maternal and fetal needs and warrant close monitoring and possible adjustment of the treatment plan to ensure optimal outcomes.

Section 2

As the clinical team implements the initial interventions, the nursing staff closely monitors the patient's response to treatment. Within the first few hours of magnesium sulfate administration, the patient reports feeling flushed and slightly drowsy, common side effects that the staff anticipates and manages through reassurance and frequent assessments. The patient's blood pressure shows a slight improvement, dropping to 145/90 mmHg, yet remains a point of concern, necessitating continued monitoring for any signs of worsening preeclampsia. The reflexes remain brisk, and the edema persists, underscoring the need for vigilant observation for any further signs of deterioration.

The corticosteroids are administered successfully, with the goal of accelerating fetal lung maturity over the next 48 hours. During this crucial window, the team focuses on evaluating the effectiveness of the interventions and the stability of the maternal-fetal dyad. Continuous fetal monitoring reveals intermittent variable decelerations that persist, though they are less frequent, suggesting a tentative improvement in fetal status. However, the discordant growth patterns remain unchanged, keeping intrauterine growth restriction as a critical concern.

The next morning, a new set of laboratory tests is drawn to assess the progression of the maternal condition. The results show a slight increase in proteinuria to 0.7 g/day, indicating a potential escalation of the preeclampsia. The platelet count has decreased further to 110,000/mm³, heightening the suspicion for HELLP syndrome and necessitating a collaborative discussion among the obstetric, hematology, and neonatology teams to reassess the management plan. The interdisciplinary team now faces the challenge of determining the optimal timing for delivery, weighing the risks of continued pregnancy against the potential benefits of further fetal maturation. This balance will guide the next steps in the patient's care journey, as the focus shifts to ensuring both maternal stabilization and fetal well-being.

Section 3

As the day progresses, the clinical team observes a change in the patient's status that demands immediate attention. The patient begins to exhibit increased right upper quadrant pain, a clinical sign that prompts the team to reassess for potential hepatic involvement indicative of worsening HELLP syndrome. Concurrently, the patient reports a worsening headache and slight visual disturbances, symptoms that align with the progression of severe preeclampsia. These developments necessitate an urgent re-evaluation of the treatment plan, as the risks of continuing the pregnancy appear to be increasing.

In response to the patient's changing condition, an ultrasound is performed to reassess fetal well-being and placental function. The findings reveal a further decrease in amniotic fluid volume, with an amniotic fluid index (AFI) now measuring at 5 cm, signaling oligohydramnios. Additionally, the biophysical profile score has dropped to a concerning 6/10, highlighting the need for close monitoring and potentially expedited intervention. The fetal heart rate tracing continues to show intermittent variable decelerations, though fetal movement and tone remain reassuring for the time being.

Given these new complications, the interdisciplinary team, including obstetrics, maternal-fetal medicine, and neonatology, convenes to deliberate on the timing of delivery. The team weighs the benefits of potential corticosteroid effects on fetal lung maturity against the risks posed by the mother's deteriorating condition. The consensus leans towards preparing for an expedited delivery, with plans to initiate labor induction under close surveillance if the patient's status stabilizes further or to proceed with a cesarean section if any rapid deterioration occurs. This decision underscores the delicate balance required in managing multiple pregnancies complicated by severe preeclampsia and potential HELLP syndrome, ensuring both maternal safety and the best possible neonatal outcomes.

Section 4

As the clinical team prepares for the possibility of expedited delivery, the patient's condition continues to evolve. During a routine check, the nurse observes a sudden spike in the patient's blood pressure, now recorded at 170/110 mmHg, despite ongoing antihypertensive therapy. This alarming escalation prompts immediate laboratory tests to reassess her hepatic and renal function, given the potential progression of HELLP syndrome. The lab results reveal a further decline in platelet count to 95,000/μL, elevated liver enzymes with AST at 150 U/L and ALT at 175 U/L, and worsening proteinuria. These findings confirm the worsening of the patient's condition, necessitating urgent intervention.

Simultaneously, the patient's neurological symptoms intensify. Her headache becomes more persistent and severe, and she experiences more pronounced visual scotomata. These symptoms indicate a high risk of developing eclampsia, a life-threatening complication. The clinical team, therefore, increases the dose of magnesium sulfate to prevent seizures while closely monitoring for any signs of magnesium toxicity. The interdisciplinary team reassesses the balance between maternal and fetal risks and concludes that immediate delivery is imperative to prevent further complications.

With the decision made, the team swiftly transitions the patient for a cesarean section. Throughout the preparation, the anesthesiology team ensures that the patient is optimally managed for both pain and blood pressure control, recognizing the precarious nature of her condition. The neonatal team stands ready to provide immediate care to the newborns, anticipating potential challenges related to their premature birth. As the surgical team proceeds, they remain vigilant for any intraoperative complications, underscoring the complexity and urgency of managing a multiple pregnancy complicated by severe preeclampsia and HELLP syndrome.

Section 5

As the surgical team initiates the cesarean section, the patient's vital signs are closely monitored. Her blood pressure remains elevated at 160/105 mmHg, and her heart rate is slightly tachycardic at 105 beats per minute. Throughout the procedure, the anesthesiology team administers continuous intravenous antihypertensive medications to maintain hemodynamic stability. Despite these efforts, the patient's oxygen saturation begins to marginally decline, registering at 92% on room air, prompting the anesthesiology team to initiate supplemental oxygen. This slight desaturation raises concern for potential pulmonary edema, a recognized complication of severe preeclampsia, necessitating vigilant observation of her respiratory status.

Intraoperatively, the obstetric team encounters significant uterine atony, which poses a risk for excessive blood loss. The team promptly administers uterotonics to stimulate uterine contraction and mitigate hemorrhage. Concurrently, the neonates are delivered and promptly assessed by the neonatal team. Both infants exhibit signs of respiratory distress, characterized by grunting and intercostal retractions, indicative of surfactant deficiency common in preterm births. They are swiftly stabilized with positive pressure ventilation and transported to the neonatal intensive care unit for further management.

Postoperatively, the patient's condition remains critical but stable. Her blood pressure gradually decreases to 140/90 mmHg under continued magnesium sulfate therapy, and her headache and visual disturbances show slight improvement. However, the ongoing risk of postpartum hemorrhage and potential complications from her underlying HELLP syndrome requires continuous monitoring. The clinical team remains on high alert for any signs of further deterioration, ready to implement additional interventions as needed. This complex case underscores the intricate balance required to manage both maternal and fetal well-being in the context of severe pregnancy complications.